989 related items for PubMed ID: 12136475
1. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskiĭ VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG.
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[Abstract] [Full Text] [Related]
2. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E, Akkaya BK, Akman S, Karpuzoglu G, Guven AG.
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[Abstract] [Full Text] [Related]
3. [Primary focal segmental glomerulosclerosis: clinical and morphological prognostic factors].
Shilov EM, Tareeva IE, Ivanov AA, Lavrova ON, Krasnova TN, Khudova IIu, Miroshnichenko NG, Ratner MIa, Biriukova LS.
Ter Arkh; 2000; 72(6):21-5. PubMed ID: 10900643
[Abstract] [Full Text] [Related]
4. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM, Dimitrjević JZ, Nikolić VN, Ognjanović MV, Rodić BD, Slavković BV.
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[Abstract] [Full Text] [Related]
5. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y, Hosoya M, Takahashi A, Isome M, Tanji M, Suzuki H.
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[Abstract] [Full Text] [Related]
6. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[Abstract] [Full Text] [Related]
7. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF, Júnior GB, Barros FA, Sousa DC, Franco LM, Patrocínio RM.
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[Abstract] [Full Text] [Related]
8. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW, Fluck RJ, Lambie SH.
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[Abstract] [Full Text] [Related]
9. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[Abstract] [Full Text] [Related]
10. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Iitaka K, Yamamoto A, Ogawa N, Sekine T, Tamai S, Motoyama O.
Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
[Abstract] [Full Text] [Related]
11. [The immunohistochemical heterogeneity of mesangioproliferative glomerulonephritis].
Varshavskiĭ VA, Gasanov AB.
Arkh Patol; 1990 Dec; 52(8):33-7. PubMed ID: 1704206
[Abstract] [Full Text] [Related]
12. Factors predicting progression of IgA nephropathies.
Coppo R, D'Amico G.
J Nephrol; 2005 Dec; 18(5):503-12. PubMed ID: 16299675
[Abstract] [Full Text] [Related]
13. [Mesangioproliferative glomerulonephritis with IgM deposits as an independent form of nephritis].
Serov VV, Varshavskiĭ VA, Gasanov AB.
Arkh Patol; 1990 Dec; 52(2):19-23. PubMed ID: 2191638
[Abstract] [Full Text] [Related]
14. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[Abstract] [Full Text] [Related]
15. Studies on circulating immune complexes. II: Circulating immune complexes in primary IgA nephropathy and membranoproliferative glomerulonephritis.
Miura Y.
Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):193-200. PubMed ID: 2739118
[Abstract] [Full Text] [Related]
16. [Clinical implications of DNA-topoisomerases examination in renal biopsies from patients with nephritis].
Ivanova LV, Shilov EM, Ivanov AA, Kozlovskaia LV, Rudolph P, Proppe D.
Ter Arkh; 2003 Feb; 75(6):11-7. PubMed ID: 12920952
[Abstract] [Full Text] [Related]
17. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS.
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[Abstract] [Full Text] [Related]
18. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K, Nakamura S, Moriya S, Koshino H, Iwasaki N, Motoyama O, Sakai T.
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[Abstract] [Full Text] [Related]
19. [Clinicopathological correlation of young onset chronic glomerulonephritis].
Naito S, Kitagawa T.
Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):275-86. PubMed ID: 2739125
[Abstract] [Full Text] [Related]
20. [Prognosis of chronic glomerulonephritis--study on renal survival ratio of mesangial proliferative glomerulonephritis and membranoproliferative glomerulonephritis].
Saito T, Sato H, Kinoshita Y, Seino J, Furuyama T, Yoshinaga K.
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):959-65. PubMed ID: 2263026
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
